Corticosteroids in advanced cancer
- PMID: 11252935
Corticosteroids in advanced cancer
Abstract
Despite the fact that there are only a few controlled trials demonstrating the benefits associated with the use of corticosteroids in specific situations, these agents are administered frequently to patients with advanced cancer. Corticosteroids may be used alone or as adjuvants in combination with other palliative or antineoplastic treatments. For example, corticosteroids may help prevent nausea, vomiting, and hypersensitivity reactions to treatment with chemotherapy or radiation. They are also commonly used as appetite stimulants in patients with advanced cancer. In the adjuvant setting, corticosteroids help to alleviate pain in advanced cancer patients, including specific situations such as back pain related to epidural compression. This article reviews the evidence supporting the use of corticosteroids in a broad range of situations seen in patients with advanced cancer.
Similar articles
-
The risks and benefits of corticosteroids in advanced cancer.Drug Saf. 1994 Sep;11(3):163-78. doi: 10.2165/00002018-199411030-00003. Drug Saf. 1994. PMID: 7811399 Review.
-
Corticosteroids and lorazepam as antiemetics in cancer chemotherapy.Drug Ther Bull. 1986 Jun 16;24(12):46-8. Drug Ther Bull. 1986. PMID: 3720551 No abstract available.
-
Corticosteroids underemployment in delayed chemotherapy-induced nausea and emesis with poor adherence to American Society of Clinical Oncology guidelines: is this a reasonable clinical choice for the elderly?J Clin Oncol. 2003 Nov 1;21(21):4066-7; author reply 4067-8. doi: 10.1200/JCO.2003.99.128. J Clin Oncol. 2003. PMID: 14581432 No abstract available.
-
The role of corticosteroids in the treatment of pain in cancer patients.Curr Pain Headache Rep. 2012 Aug;16(4):307-13. doi: 10.1007/s11916-012-0273-z. Curr Pain Headache Rep. 2012. PMID: 22644902 Free PMC article. Review.
-
The use of corticosteroids in reducing cancer-related fatigue: assessing the evidence for clinical practice.Int J Palliat Nurs. 2016 Jan;22(1):5-9. doi: 10.12968/ijpn.2016.22.1.5. Int J Palliat Nurs. 2016. PMID: 26804950 Review.
Cited by
-
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.Oncoscience. 2016 Jul 27;3(7-8):188-202. doi: 10.18632/oncoscience.315. eCollection 2016. Oncoscience. 2016. PMID: 27713909 Free PMC article. Review.
-
The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial.Support Care Cancer. 2021 Apr;29(4):2047-2055. doi: 10.1007/s00520-020-05693-6. Epub 2020 Aug 27. Support Care Cancer. 2021. PMID: 32856209 Free PMC article. Clinical Trial.
-
Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol.Front Oncol. 2019 Jan 18;8:643. doi: 10.3389/fonc.2018.00643. eCollection 2018. Front Oncol. 2019. PMID: 30713832 Free PMC article.
-
Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo.J Endocrinol. 2020 May;245(2):207-218. doi: 10.1530/JOE-19-0473. J Endocrinol. 2020. PMID: 32106090 Free PMC article.
-
Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study.J Natl Compr Canc Netw. 2021 Mar 10;19(6):709-718. doi: 10.6004/jnccn.2020.7653. J Natl Compr Canc Netw. 2021. PMID: 34129522 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical